Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link Semaglutide vs. Tirzepatide for Weight Loss DrNewMed Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Tirzepatide: a new low for bodyweight and blood glucose The Lancet Diabetes & Endocrinology New Developments in Pharmacological Treatment of Obesity and Type 2 DiabetesBeyond and within GLP 1 Receptor Agonists Amylin Commands Weight Loss Attention as Industry Anticipates Novo's Phase III CagriSema Readout BioSpace